GTX Inc (GTXI.OQ)
GTXI.OQ on NASDAQ Stock Exchange Capital Market
14.87USD
16 Jul 2018
14.87USD
16 Jul 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$14.87
$14.87
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
39,132
39,132
52-wk High
$23.36
$23.36
52-wk Low
$5.31
$5.31
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 0.00 | -0.617 |
| FY 2017 | Dec '17 | 0.00 | -0.430 |
| Sep '17 | 0.00 | -0.528 | |
| Jun '17 | 0.00 | -0.399 | |
| Mar '17 | 0.00 | -0.390 | |
| FY 2016 | Dec '16 | 0.00 | -0.437 |
| Sep '16 | 0.00 | -0.487 | |
| Jun '16 | 0.00 | -0.427 | |
| Mar '16 | 0.00 | 0.147 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Dec-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-19 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 2 | -0.41 | -0.39 | -0.44 | -- |
| Quarter Ending Dec-18 | 2 | -0.41 | -0.36 | -0.45 | -- |
| Year Ending Dec-18 | 2 | -1.87 | -1.78 | -1.95 | -- |
| Year Ending Dec-19 | 2 | -1.80 | -1.77 | -1.84 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Dividends
Growth Rates
Financial Strength
Profitability Ratios
Efficiency
Management Effectiveness
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | 8.64 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for GTX Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- Deutsche Boerse beefs up forex business with $100 million buy
- Deutsche Boerse beefs up forex business with $100 mln buy
- BRIEF-GTX Announces Early Completion Of Patient Enrollment In The Astrid Trial
- BRIEF-GTX Inc Q4 Loss Per Share $0.43
- BRIEF-GTx Announced New Data Demonstrating Enobosarm's Potential To Treat Stress Urinary Incontinence At SUFU 2018
Institutional Holders
| % Shares Owned: | 39.77% |
| # of Holders: | 57 |
| Total Shares Held: | 8,960,412 |
| 3 Mo. Net Change: | 1,664,023 |
| # New Positions: | 4 |
| # Closed Positions: | 0 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.